isoproterenol has been researched along with disulfiram in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (25.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Murnaghan, MF | 1 |
| Sourkes, TL; Wong, KP | 1 |
| Amabeoku, GJ; Syce, JA | 1 |
1 review(s) available for isoproterenol and disulfiram
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
7 other study(ies) available for isoproterenol and disulfiram
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Restoration of the chronotropic effect of tyramine on rat atria after reserpine.
Topics: Animals; Disulfiram; Dopamine; Epinephrine; Heart; Heart Atria; Heart Rate; In Vitro Techniques; Iproniazid; Isoproterenol; Monoamine Oxidase Inhibitors; Norepinephrine; Octopamine; Oxidoreductases; Phenylephrine; Rats; Reserpine; Sympathomimetics; Synephrine; Thiocarbamates; Tyramine | 1968 |
Metabolism of vanillin and related substances in the rat.
Topics: Acetophenones; Acids; Animals; Catechols; Chromatography, Thin Layer; Disulfiram; Flavoring Agents; Guaiacol; Isoproterenol; Neomycin; Phenols; Rats; Streptomycin | 1966 |
Propranolol-induced seizures in mice: the role of noradrenaline.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Adrenergic Uptake Inhibitors; alpha-Methyltyrosine; Animals; Disulfiram; Droxidopa; Drug Synergism; Female; Imipramine; Isoproterenol; Male; Mice; Norepinephrine; Pargyline; Propranolol; Reserpine; Seizures | 1997 |